Developer docs
API playgroundTry for free, no card

Search company profiles

Sonormed GmbH

Full company profile

uuid000bgjy

Namestring
Sonormed GmbH
Legal namestring
Sonormed GmbH
Websiteurl
tinnitracks.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Sonormed GmbH is a Hamburg-based medical technology company founded in 2012 that operates in digital audiology through a single product, the Meine Tinnitus App. The app delivers a structured 10-week digital therapeutic based on the Tinnitus Counseling methodology for patients with subjective tinnitus, which the company notes accounts for approximately 99% of tinnitus cases. It is registered as a Class I CE-marked medical device and listed in the German BfArM DiGA directory (listing ID 01496).

The app is built as a mobile application for iOS and Android, with adaptive lesson composition driven by an initial patient questionnaire that targets the most burdensome co-occurring symptoms (sleep, emotional, hearing, concentration). Content is delivered across reading, audio, video, interactive games, and quizzes, and the app remains functional offline after initial registration and license activation.

The business model is primarily prescription-based: patients obtain a prescription from any physician or psychotherapist, submit it to their German statutory health insurer (gesetzliche Krankenkasse), receive a 16-digit activation code, and download the app — with the insurer reimbursing the company at the regulated DiGA price. A secondary channel via Digistore24 serves privately insured and self-paying patients. Distribution and customer service are handled operationally through a partnership with Infectopharm Digital Health, and the Avi Medical video consultation integration supports prescription access without an in-person visit.

Short descriptiontext

Sonormed GmbH operates Meine Tinnitus App, a German DiGA-listed digital therapeutic that delivers a 10-week Tinnitus Counseling program to patients with subjective tinnitus, reimbursed by statutory health insurers on prescription and supplemented by direct private-pay purchase.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
digital health applications, tinnitus management software, prescription digital therapeutics, audiology mobile apps, tinnitus counseling programs
Industry1 code
PRIMARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Therapeutics / Digital Health Applications (DiGA)
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Statutory Health Insurance Reimbursement
TypeSubscription Recurring
Description

Patients with German statutory (gesetzliche) health insurance receive the app at no cost when they have a valid prescription. The company bills the health insurer directly after the patient exchanges their prescription for an activation code. This is the primary revenue stream.

meinetinnitusapp.de
2Direct Purchase (Private Patients)
TypeOne Time License
Description

Privately insured patients or those without statutory coverage can purchase the app directly via Digistore24. A PDF invoice is provided for submission to the private insurer for potential reimbursement.

meinetinnitusapp.de
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Statutory Health Insurance — 100% Covered
ModelSubscriptionBilling cadenceAnnual
Notes

Full cost covered by German statutory health insurers upon prescription. No patient co-payment. Includes 12 months of access to all app content.

meinetinnitusapp.de
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 record
1Meine Tinnitus App
Description

A digital tinnitus counseling app that provides interactive lessons for managing tinnitus. The app is registered as a Class 1 medical device and listed in the German DiGA (Digital Health Applications) directory. It offers personalized lessons addressing tinnitus-related symptoms such as sleep disturbances, emotional distress, hearing problems, and concentration deficits.

meinetinnitusapp.de
Core offering1 text field

Sonormed GmbH develops and operates "Meine Tinnitus App," a CE-marked Class I medical device and prescription digital health application (DiGA) listed in the German BfArM directory (listing ID 01496). The app delivers a 10-week structured Tinnitus Counseling program for adults with subjective tinnitus, with adaptive multimedia lessons (reading, audio, video, interactive games, quizzes) personalized to each patient's most burdensome co-occurring symptoms. The app is fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, and is available via direct purchase through Digistore24 for privately insured patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Clinically proven significant reduction in tinnitus burden within 10 weeks vs. non-users (p<0.001)
Product overview1 text field

Sonormed GmbH operates as a digital health company offering a single core product: Meine Tinnitus App. This app-based digital health application (DiGA) delivers a structured 10-week therapy program grounded in Tinnitus Counseling methodology, providing personalized lessons adapted to individual patient symptoms. The product is available via prescription for statutory health insurance members (fully covered) or direct purchase for private insurance users.

Product and service1 record
1Meine Tinnitus App
CategoryDigital Therapeutics / Prescription Digital Health Application (DiGA) for tinnitus
Description

A digital health application (DiGA) for adult patients in Germany diagnosed with subjective tinnitus. Delivers a structured 10-week Tinnitus Counseling program of weekly lessons (60–90 minutes each) using adaptive multimedia content (readings, audio, video, interactive games, quizzes) personalized to the patient's most burdensome co-occurring symptoms (sleep disturbance, emotional distress, hearing problems, concentration deficits). Available fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, or via direct purchase through Digistore24 for privately insured patients.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Infectopharm Digital Health is the company behind Meine Tinnitus App. It handles customer service (phone and email support), billing with health insurers, and overall product distribution. The app is branded and marketed as an 'innovative App von Infectopharm Digital Health'.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Avi Medical is a video consultation provider that offers patients a video appointment with a physician to obtain a prescription for Meine Tinnitus App. The consultation is free for statutorily insured patients. This partnership facilitates prescription access for patients without an in-person doctor visit.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German digital therapeutics company with multiple DiGA-listed products for mental health indications. Operates under the same DiGA regulatory and reimbursement framework as Sonormed, with analogous prescription-driven GTM and statutory-insurance billing — making it a directly comparable business model peer.

TypeDirect peer
Description

Munich-based DiGA company offering a reimbursed digital therapeutic for panic disorder and agoraphobia. Mirrors Sonormed's prescription-driven, statutory-insurance-reimbursed GTM and Class I/IIa SaMD regulatory pathway.

TypeDirect peer
Description

Berlin-based DiGA company for non-specific back pain, operating on the same BfArM-listed, statutory-health-insurance-reimbursed digital therapeutics model. Closely comparable in distribution mechanics and target customer (chronic-condition patients on prescription).

TypeDirect peer
Description

Berlin-based DiGA for irritable bowel syndrome that uses the same prescription → activation code → app download flow as Meine Tinnitus App. Direct competitor in the German DiGA category with overlapping regulatory and commercial mechanics.

TypeBroad incumbent
Description

Global hearing-aid leader (Phonak, Unitron) that bundles tinnitus therapy features into its hearing-aid companion apps. Operates in the same audiology end-market as Sonormed but with hardware as the primary revenue driver — a broader incumbent with overlapping patient populations.

TypeBroad incumbent
Description

Danish hearing-aid group behind Oticon, Bernafon, Sonic, and Philips Hearing Solutions. Offers tinnitus management features in its hearing-aid ecosystem, competing with Sonormed for the same patient population but from a hardware-centric, broader-portfolio position.

TypeBroad incumbent
Description

Owner of ReSound and Beltone hearing aids, with a dedicated tinnitus app (ReSound Tinnitus Relief). A broad incumbent in audiology that overlaps directly with Sonormed's target patient and indication.

TypeBroad incumbent
Description

US-based hearing-aid major that ships tinnitus therapy content within its companion app portfolio. Competes for the same tinnitus patient population, bundled into a hardware-plus-software offering.

TypeEmerging player
Description

US-listed digital therapeutics company (EndeavorRx for ADHD) and one of the few pure-play publicly traded DTx peers. Comparable as a clinically validated, prescription-grade software therapeutic, though operating in a different indication and reimbursement system.

TypeEmerging player
Description

Swiss/German clinical-stage biopharma developing pharmacological treatments for hearing loss and tinnitus. An emerging player addressing the same underlying condition through a different modality (drug rather than digital therapeutic), making it a useful therapeutic-area comparable for market sizing.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sonormed GmbH

Digital Therapeutics / Digital Health Applications (DiGA)tinnitracks.com

Sonormed GmbH operates Meine Tinnitus App, a German DiGA-listed digital therapeutic that delivers a 10-week Tinnitus Counseling program to patients with subjective tinnitus, reimbursed by statutory health insurers on prescription and supplemented by direct private-pay purchase.

What Sonormed GmbH does

Sonormed GmbH is a Hamburg-based medical technology company founded in 2012 that operates in digital audiology through a single product, the Meine Tinnitus App. The app delivers a structured 10-week digital therapeutic based on the Tinnitus Counseling methodology for patients with subjective tinnitus, which the company notes accounts for approximately 99% of tinnitus cases. It is registered as a Class I CE-marked medical device and listed in the German BfArM DiGA directory (listing ID 01496).

The app is built as a mobile application for iOS and Android, with adaptive lesson composition driven by an initial patient questionnaire that targets the most burdensome co-occurring symptoms (sleep, emotional, hearing, concentration). Content is delivered across reading, audio, video, interactive games, and quizzes, and the app remains functional offline after initial registration and license activation.

The business model is primarily prescription-based: patients obtain a prescription from any physician or psychotherapist, submit it to their German statutory health insurer (gesetzliche Krankenkasse), receive a 16-digit activation code, and download the app — with the insurer reimbursing the company at the regulated DiGA price. A secondary channel via Digistore24 serves privately insured and self-paying patients. Distribution and customer service are handled operationally through a partnership with Infectopharm Digital Health, and the Avi Medical video consultation integration supports prescription access without an in-person visit.

Sonormed GmbH firmographics

Firmographics
Name
Sonormed GmbH
Legal name
Sonormed GmbH
Website
https://tinnitracks.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Sonormed GmbH operates Meine Tinnitus App, a German DiGA-listed digital therapeutic that delivers a 10-week Tinnitus Counseling program to patients with subjective tinnitus, reimbursed by statutory health insurers on prescription and supplemented by direct private-pay purchase.
Ownership category
akta.pro rank

Sonormed GmbH industry classification

Industry
Product category
Digital Therapeutics / Digital Health Applications (DiGA)
NAICS
Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital health applications
  • Tinnitus management software
  • Prescription digital therapeutics
  • Audiology mobile apps
  • Tinnitus counseling programs

Where Sonormed GmbH is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Markets served

Sonormed GmbH business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Statutory Health Insurance Reimbursement: Patients with German statutory (gesetzliche) health insurance receive the app at no cost when they have a valid prescription. The company bills the health insurer directly after the patient exchanges their prescription for an activation code. This is the primary revenue stream.
  2. Direct Purchase (Private Patients): Privately insured patients or those without statutory coverage can purchase the app directly via Digistore24. A PDF invoice is provided for submission to the private insurer for potential reimbursement.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStatutory Health Insurance — 100% Covered

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Sonormed GmbH product offering

Product offering

Core offering

Sonormed GmbH develops and operates "Meine Tinnitus App," a CE-marked Class I medical device and prescription digital health application (DiGA) listed in the German BfArM directory (listing ID 01496). The app delivers a 10-week structured Tinnitus Counseling program for adults with subjective tinnitus, with adaptive multimedia lessons (reading, audio, video, interactive games, quizzes) personalized to each patient's most burdensome co-occurring symptoms. The app is fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, and is available via direct purchase through Digistore24 for privately insured patients.

Product overview

Sonormed GmbH operates as a digital health company offering a single core product: Meine Tinnitus App. This app-based digital health application (DiGA) delivers a structured 10-week therapy program grounded in Tinnitus Counseling methodology, providing personalized lessons adapted to individual patient symptoms. The product is available via prescription for statutory health insurance members (fully covered) or direct purchase for private insurance users.

Differentiator

Problem solved

Functional benefit

Brands

  • Meine Tinnitus App: A digital tinnitus counseling app that provides interactive lessons for managing tinnitus. The app is registered as a Class 1 medical device and listed in the German DiGA (Digital Health Applications) directory. It offers personalized lessons addressing tinnitus-related symptoms such as sleep disturbances, emotional distress, hearing problems, and concentration deficits.

Products and services

  • Meine Tinnitus App A digital health application (DiGA) for adult patients in Germany diagnosed with subjective tinnitus. Delivers a structured 10-week Tinnitus Counseling program of weekly lessons (60–90 minutes each) using adaptive multimedia content (readings, audio, video, interactive games, quizzes) personalized to the patient's most burdensome co-occurring symptoms (sleep disturbance, emotional distress, hearing problems, concentration deficits). Available fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, or via direct purchase through Digistore24 for privately insured patients.

Quantifiable outcome

  • Clinically proven significant reduction in tinnitus burden within 10 weeks vs. non-users (p<0.001)

Companies that use Sonormed GmbH

Customer profile

Segments1 record

Ideal customer profiles3 records

Sonormed GmbH technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sonormed GmbH partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Infectopharm Digital HealthcoreStrategic or Co-development PartnerInfectopharm Digital Health is the company behind Meine Tinnitus App. It handles customer service (phone and email support), billing with health insurers, and overall product distribution. The app is branded and marketed as an 'innovative App von Infectopharm Digital Health'.
  • Avi MedicalminorGTM or Marketing PartnerAvi Medical is a video consultation provider that offers patients a video appointment with a physician to obtain a prescription for Meine Tinnitus App. The consultation is free for statutorily insured patients. This partnership facilitates prescription access for patients without an in-person doctor visit.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Sonormed GmbH competitors and assessment

Company assessment

Direct peers

  • Selfapy: German digital therapeutics company with multiple DiGA-listed products for mental health indications. Operates under the same DiGA regulatory and reimbursement framework as Sonormed, with analogous prescription-driven GTM and statutory-insurance billing — making it a directly comparable business model peer.
  • Mindable Health: Munich-based DiGA company offering a reimbursed digital therapeutic for panic disorder and agoraphobia. Mirrors Sonormed's prescription-driven, statutory-insurance-reimbursed GTM and Class I/IIa SaMD regulatory pathway.
  • Vivira Health Lab: Berlin-based DiGA company for non-specific back pain, operating on the same BfArM-listed, statutory-health-insurance-reimbursed digital therapeutics model. Closely comparable in distribution mechanics and target customer (chronic-condition patients on prescription).
  • Cara Care: Berlin-based DiGA for irritable bowel syndrome that uses the same prescription → activation code → app download flow as Meine Tinnitus App. Direct competitor in the German DiGA category with overlapping regulatory and commercial mechanics.

Broad incumbents

  • Sonova: Global hearing-aid leader (Phonak, Unitron) that bundles tinnitus therapy features into its hearing-aid companion apps. Operates in the same audiology end-market as Sonormed but with hardware as the primary revenue driver — a broader incumbent with overlapping patient populations.
  • Demant: Danish hearing-aid group behind Oticon, Bernafon, Sonic, and Philips Hearing Solutions. Offers tinnitus management features in its hearing-aid ecosystem, competing with Sonormed for the same patient population but from a hardware-centric, broader-portfolio position.
  • GN Audio (GN Hearing): Owner of ReSound and Beltone hearing aids, with a dedicated tinnitus app (ReSound Tinnitus Relief). A broad incumbent in audiology that overlaps directly with Sonormed's target patient and indication.
  • Starkey Hearing Technologies: US-based hearing-aid major that ships tinnitus therapy content within its companion app portfolio. Competes for the same tinnitus patient population, bundled into a hardware-plus-software offering.

Emerging players

  • Akili Interactive: US-listed digital therapeutics company (EndeavorRx for ADHD) and one of the few pure-play publicly traded DTx peers. Comparable as a clinically validated, prescription-grade software therapeutic, though operating in a different indication and reimbursement system.
  • AudioCure: Swiss/German clinical-stage biopharma developing pharmacological treatments for hearing loss and tinnitus. An emerging player addressing the same underlying condition through a different modality (drug rather than digital therapeutic), making it a useful therapeutic-area comparable for market sizing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Sonormed GmbH social profiles

Digital presence

Sonormed GmbH compliance and trust

Trust signal

Compliance1 record

Sonormed GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sonormed GmbH leadership team

Management profile

Number of profiles

Profiles1 record

Sonormed GmbH funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sonormed GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonormed GmbH

What does Sonormed GmbH do?

Sonormed GmbH develops and operates "Meine Tinnitus App," a CE-marked Class I medical device and prescription digital health application (DiGA) listed in the German BfArM directory (listing ID 01496). The app delivers a 10-week structured Tinnitus Counseling program for adults with subjective tinnitus, with adaptive multimedia lessons (reading, audio, video, interactive games, quizzes) personalized to each patient's most burdensome co-occurring symptoms. The app is fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, and is available via direct purchase through Digistore24 for privately insured patients.

Is Sonormed GmbH a public or private company?

Sonormed GmbH is a private company. It is classified as venture growth investor backed and is currently operating.

When was Sonormed GmbH founded?

Sonormed GmbH was founded in 2012. It employs 1 to 10 people.

Where is Sonormed GmbH based?

Sonormed GmbH is headquartered in Hamburg, Germany, in the Europe region.

How does Sonormed GmbH make money?

Two revenue lines are on record. Statutory Health Insurance Reimbursement is the primary driver. The others are direct Purchase (Private Patients).

Who are Sonormed GmbH's main competitors?

Direct peers on record are Selfapy, Mindable Health, Vivira Health Lab and Cara Care. Broad incumbents are Sonova, Demant, GN Audio (GN Hearing) and Starkey Hearing Technologies. Emerging players are Akili Interactive and AudioCure.

Does Sonormed GmbH have an API?

No public API is recorded for Sonormed GmbH.

What industry is Sonormed GmbH in?

Sonormed GmbH's product category is Digital Therapeutics / Digital Health Applications (DiGA). Its primary akta.pro industry code is HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 62134 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals